SI1403275T1 - Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli - Google Patents

Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli

Info

Publication number
SI1403275T1
SI1403275T1 SI200330102T SI200330102T SI1403275T1 SI 1403275 T1 SI1403275 T1 SI 1403275T1 SI 200330102 T SI200330102 T SI 200330102T SI 200330102 T SI200330102 T SI 200330102T SI 1403275 T1 SI1403275 T1 SI 1403275T1
Authority
SI
Slovenia
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
SI200330102T
Other languages
English (en)
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SI1403275T1 publication Critical patent/SI1403275T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI200330102T 2003-02-28 2003-02-28 Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli SI1403275T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290485A EP1403275B1 (fr) 2003-02-28 2003-02-28 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
SI1403275T1 true SI1403275T1 (sl) 2006-02-28

Family

ID=31970533

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330102T SI1403275T1 (sl) 2003-02-28 2003-02-28 Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli

Country Status (18)

Country Link
US (1) US7166633B2 (sl)
EP (1) EP1403275B1 (sl)
JP (1) JP4563372B2 (sl)
CN (1) CN1326871C (sl)
AR (1) AR043409A1 (sl)
AT (1) ATE307139T1 (sl)
AU (1) AU2004217599B2 (sl)
DE (1) DE60301930T2 (sl)
DK (1) DK1403275T3 (sl)
EA (1) EA009066B1 (sl)
ES (1) ES2250846T3 (sl)
HK (1) HK1086281A1 (sl)
MY (1) MY136989A (sl)
NZ (1) NZ541424A (sl)
PL (1) PL215131B1 (sl)
SI (1) SI1403275T1 (sl)
WO (1) WO2004078107A2 (sl)
ZA (1) ZA200505781B (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1403275T3 (da) * 2003-02-28 2005-12-05 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
WO2006069799A1 (en) * 2004-12-28 2006-07-06 Dsm Ip Assets B.V. Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
CN105828892B (zh) 2013-12-27 2018-05-15 株式会社宝登 球
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
CN100448675C (zh) * 2002-02-07 2009-01-07 株式会社理光 喷墨装置、压强调节机构及喷墨打印机
DK1403275T3 (da) * 2003-02-28 2005-12-05 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Also Published As

Publication number Publication date
DE60301930D1 (de) 2006-03-02
AR043409A1 (es) 2005-07-27
HK1086281A1 (en) 2006-09-15
PL215131B1 (pl) 2013-10-31
WO2004078107A3 (fr) 2004-10-21
ES2250846T3 (es) 2006-04-16
EA009066B1 (ru) 2007-10-26
NZ541424A (en) 2008-03-28
EP1403275B1 (fr) 2005-10-19
WO2004078107A2 (fr) 2004-09-16
ATE307139T1 (de) 2005-11-15
PL377238A1 (pl) 2006-01-23
MY136989A (en) 2008-12-31
CN1326871C (zh) 2007-07-18
DE60301930T2 (de) 2006-07-27
JP4563372B2 (ja) 2010-10-13
JP2006519177A (ja) 2006-08-24
ZA200505781B (en) 2006-11-29
AU2004217599A1 (en) 2004-09-16
US7166633B2 (en) 2007-01-23
EA200501258A1 (ru) 2006-04-28
AU2004217599B2 (en) 2009-07-30
EP1403275A1 (fr) 2004-03-31
CN1753906A (zh) 2006-03-29
US20060149081A1 (en) 2006-07-06
DK1403275T3 (da) 2005-12-05

Similar Documents

Publication Publication Date Title
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
ME01396B (me) Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih aditivnih soli kiselina
AP2002002630A0 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HU0300231D0 (en) Process for the preparation of high purity perindopril and intermediates use ful in the synthesis
PT1753720E (pt) Processo para a preparação de perindopril e sais do mesmo
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
SI1367061T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
ZA200500422B (en) Process for the preparation of phenylalanine enamide derivatives
SI1371659T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
HK1086281A1 (en) Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096406A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
SI1422236T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
AU2003260942A8 (en) A process for the preparation of oxindole derivatives
AU2003210296A8 (en) Process for the preparation of 4-hetero-substituted phenylalanine derivatives
SI1268424T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli